Fluent BioSciences Debuts PIPseq V With Unique Molecular Counting Strategy
Fluent BioSciences Debuts PIPseq V With Unique Molecular Counting Strategy
Novel TruID method Increases transcript yield and overall assay sensitivity.
小說 truID 方法提高轉錄物產量和總體檢測靈敏度。
CAMBRIDGE, Mass., May 29, 2024 /PRNewswire/ -- Fluent BioSciences, a leader in single-cell technology innovation, is proud to herald the launch of our latest product line, the PIPseq V 3' Single Cell RNA Sequencing Kits. This new release marks a significant advancement in molecular quantification, demonstrating our commitment to driving transformative progress in single-cell biology.
馬薩諸塞州劍橋，2024年5月29日 /PRNewswire/ — 單細胞技術創新領域的領導者Fluent BioSciences自豪地宣佈我們的最新產品線Pipseq V 3'單細胞RNA測序試劑盒的推出。這一新版本標誌着分子定量學的重大進步，表明了我們對推動單細胞生物學變革性進步的承諾。
Designed to apply to a broad range of research needs, an assortment of PIPseq V kits address a wide scope of sample types and input levels. This scalability makes our product line an affordable option for both small and large-scale projects. The PIPseq V 3' kits bring numerous enhancements over previous versions, delivering notable improvements in both performance and workflow simplicity:
各種 PipSeq V 套件專爲滿足廣泛的研究需求而設計，可滿足廣泛的樣本類型和輸入水平。這種可擴展性使我們的產品線成爲小型和大型項目的經濟實惠的選擇。與以前的版本相比，PipSeq V 3' 套件帶來了許多增強，在性能和工作流程簡便性方面均有顯著改進：
- Enhances Gene and Transcript Detection
- Streamlines Workflow
- Eliminates UMI-specific biases
- PIPseq Replay: Re-interrogate cDNA
- 增強基因和轉錄本檢測
- 簡化工作流程
- 消除特定於 UMI 的偏見
- PipSeq 重播: 重新查詢 cDNA
Our cutting-edge TruID technology leverages the random fragmentation of RNA to generate intrinsic identifiers, dramatically enhancing precision and sensitivity. This novel approach reframes the way single-cell experiments are performed and analyzed.
我們尖端的 TruID 技術利用 RNA 的隨機片段生成固有標識符，從而顯著提高了精度和靈敏度。這種新穎的方法重塑了進行和分析單細胞實驗的方式。
"As Fluent BioSciences continues to lead the charge in innovation within our field, we are delighted to offer a glimpse into an upcoming advancement in single-cell technology," said Brian McKernan, CEO of Fluent BioSciences. "Our forthcoming PIPseq release includes a significant innovation in molecular counting methodologies, promising unparalleled gains in precision and sensitivity increasing yield of transcripts and genes without raising the background giving better visibility to low abundance cell types. This breakthrough opens doors to a myriad of possibilities for enhanced research and analysis capabilities."
Fluent BioSciences首席執行官布萊恩·麥克南表示：“隨着Fluent BioSciences繼續引領我們領域的創新，我們很高興向大家介紹單細胞技術即將取得的進步。”“我們即將發佈的PipSeq版本包括分子計數方法的重大創新，有望在不提高背景的情況下提高轉錄本和基因的產量，從而提高低丰度細胞類型的可見度，從而在不提高背景的情況下提高精度和靈敏度。這一突破爲增強研究和分析能力的衆多可能性打開了大門。”
The PIPseq V 3' Single Cell RNA Sequencing Kits are poised to set a new standard in the industry, empowering researchers with tools that enable more detailed and precise single-cell studies. Contact our team at [email protected] for more information or to purchase the PIPseq V kits.
PipSeq V 3' 單細胞 RNA 測序試劑盒有望在行業中樹立新標準，爲研究人員提供實現更詳細、更精確的單細胞研究的工具。請通過以下方式聯繫我們的團隊 [電子郵件保護] 欲了解更多信息或購買 PipSeq V 套件。
SOURCE Fluent BioSciences
來源 Fluent BioSc
譯文內容由第三人軟體翻譯。